Human genetic variation reveals FCRL3 is a lymphocyte receptor for Yersinia pestis
Yersinia pestis is the bacterium responsible for plague, one of the deadliest diseases in history. To discover human genetic determinants of Y. pestis infection, we utilized nearly 1,000 genetically diverse lymphoblastoid cell lines in a cellular genome-wide association study. A nonsynonymous SNP, rs2282284 (N721S), in Fc receptor-like 3 (FCRL3) was associated with bacterial invasion of host cells (p = 9 × 10<sup>-8</sup>). Overexpressed FCRL3 facilitated attachment and invasion of Y. pestis and colocalized with Y. pestis at attachment sites. These properties were variably conserved across the FCRL family, revealing an immunoglobulin-like domain and signaling motifs shared by FCRL3 and FCRL5 to be necessary for attachment and invasion. Direct binding to FCRL5 extracellular domain was confirmed, and B cells (the primary cells that express FCRLs) were preferentially invaded by Y. pestis. Thus, Y. pestis hijacks FCRL proteins, possibly taking advantage of an immune receptor to create a lymphocyte niche during infection.
Authors
- Sam Shi
- T. Wilson (ORCID: https://orcid.org/0000-0001-8403-9401)
- Trisha Dalapati (ORCID: https://orcid.org/0000-0001-6319-5253)
- Liuyang Wang (ORCID: https://orcid.org/0000-0001-9556-2361)
- Micah A. Luftig (ORCID: https://orcid.org/0000-0002-2964-1907)
- Samuel I. Miller (ORCID: https://orcid.org/0000-0003-1638-2181)
- Nicolás M. Reinoso-Vizcaíno (ORCID: https://orcid.org/0000-0002-9769-3768)
- Dennis C. Ko (ORCID: https://orcid.org/0000-0002-0113-5981)
- Rachel M. Keener
Institutions
- Duke University (US)
- University of Washington (US)
- Miami University (US)
Publication Details
- Journal
- Cell Genomics
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1016/j.xgen.2025.100917
- Citations
- 1
- Primary Topic
- Yersinia bacterium, plague, ectoparasites research
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- National Institutes of Health
- School of Medicine, Duke University
- Triangle Comparative and Evolutionary Medicine Center, Duke University
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases